Suzuken Co., Ltd. (TYO:9987)
Japan flag Japan · Delayed Price · Currency is JPY
5,105.00
+34.00 (0.67%)
Aug 26, 2026, 10:32 AM JST

Suzuken Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,522,7372,486,6472,399,9522,386,4932,314,8282,232,774
Revenue Growth
4.65%3.61%0.56%3.10%3.67%4.91%
Gross Profit
192,609192,525192,232185,249179,695160,994
Operating Income
34,99236,37637,12634,87632,60613,778
Net Income
37,73538,13634,49629,01620,34514,393
Earnings Per Share
548.08545.54454.58357.87236.46163.18
EPS Growth
22.46%20.01%27.02%51.34%44.91%84.35%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Intersegment sales and transactions
-539,589-539,004-398,718-323,051-272,907-226,081
Community Healthcare and Nursing Care Support Business
93,54093,93794,41497,46387,74288,821
Pharmaceutical Distribution
2,437,2282,401,0132,313,9672,299,1802,226,9182,144,335
Healthcare Product Development
51,90751,63652,61351,29644,38243,938
Healthcare Related Services
-42,96442,188261,604228,691181,761
Specialty Drug Contract Distribution Business
-436,100295,485---
Total
2,522,7362,486,6462,399,9492,386,4922,314,8262,232,774

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
148,783141,671141,582242,112192,703201,463
Total Debt
------
Net Cash (Debt)
148,783141,671141,582242,112192,703201,463
Net Cash Growth
4.63%0.06%-41.52%25.64%-4.35%-5.02%
Net Cash Per Share
2199.702026.621865.722986.122239.722284.08

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-33,566-65,07987,21637,2709,520
Capital Expenditures
--15,064-14,307-10,810-15,058-11,155
Free Cash Flow
-18,502-79,38676,40622,212-1,635
Free Cash Flow Growth
---243.98%--

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
-7.74%8.01%7.76%7.76%7.21%
Operating Margin
1.39%1.46%1.55%1.46%1.41%0.62%
Pretax Margin
2.11%2.18%2.10%1.79%1.32%1.01%
Profit Margin
1.50%1.53%1.44%1.22%0.88%0.65%
FCF Margin
-0.74%-3.31%3.20%0.96%-0.07%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
120.000100.000100.00080.00072.00072.000
Dividend Per Share Growth
10.00%0%25.00%11.11%0%0%
Dividend Yield
2.38%1.69%2.06%1.79%2.27%2.14%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
9.2510.5310.3212.4113.6022.18
Forward PE
13.9613.5814.1616.9513.8620.76
P/FCF Ratio
18.5421.70-4.7112.46-
PS Ratio
0.140.160.150.150.120.14